Tag: SGX301

Soligenix all set to begin FLASH clinical trial for SGX301 in CTCL

pharmanewsdaily- December 4, 2019

US biopharma company Soligenix has wrapped up enrolling patients for its phase 3 Fluorescent Light Activated Synthetic Hypericin clinical trial (FLASH clinical trial) for SGX301 ... Read More